Where can I learn more about this study?
You can find more information about this study on the websites listed below. If more information
about the study results is available, it can also be found here.
X www.clinicaltrials.gov Once you are on the website, type “NCT04362410”
into the search box and click “Search”.
X www.AstraZenecaClinicalTrials.com Once you are on the website, type “D5180C00020”
into the search box and click “Find a Study”.
Full Study Title: A Phase 1, Single Centre, Double-blind, Randomized, Placebo-controlled
Parallel-group Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Immunogenicity
of Tezepelumab after Single-Dose Subcutaneous Administration in Healthy Chinese Subjects
(DIRECTION-CK)
AstraZeneca AB Protocol Number: D5180C00020
National Clinical Trials Number: NCT04362410
AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer
important health questions and find medical treatments for patients.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on
educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants
for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org
Version 1.0_2022_03_16
8 | Clinical Study Results